![Kohichiro Yoshino](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kohichiro Yoshino
President chez
CARNA BIOSCIENCES, INC.
Fortune : 883 045 $ au 31/05/2026
Profil
Kohichiro Yoshino is President & Representative Director at Carna Biosciences, Inc. since 2017.
Holds the position of Independent Outside Director at MEDINET Co., Ltd. and Kringle Pharma, Inc. since 2018.
Serves as Director at CarnaBio USA, Inc. since 2011.
Formerly President & Representative Director at ProbeX, Inc. Completed a doctorate at Kyoto University and graduate studies at the Institute of Science Tokyo.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2025 | 333 900 ( 1,74% ) | 883 045 $ | 31/05/2026 |
Postes actifs de Kohichiro Yoshino
| Sociétés | Poste | Début |
|---|---|---|
| CARNA BIOSCIENCES, INC. | President | 10/04/2003 |
| MEDINET CO., LTD. | Directeur/Membre du Conseil | 01/12/2018 |
| KRINGLE PHARMA, INC. | Directeur/Membre du Conseil | 01/12/2018 |
CarnaBio USA, Inc.
 CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Directeur/Membre du Conseil | 01/03/2011 |
Anciens postes connus de Kohichiro Yoshino
| Sociétés | Poste | Fin |
|---|---|---|
ProbeX, Inc.
 ProbeX, Inc. Medical/Nursing ServicesHealth Services Develops, manufactures, and distributes molecular imaging probe reagents | President | - |
Formation de Kohichiro Yoshino
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
17
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Carna Biosciences, Inc.
 Carna Biosciences, Inc. BiotechnologyHealth Technology Engages in the drug discovery business | Health Technology |
MEDINET Co., Ltd.
 MEDINET Co., Ltd. BiotechnologyHealth Technology Engages in the contract development and manufacturing organization which provides regenerative medicine & cell therapy services | Health Technology |
Kyoto University
 Kyoto University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tokyo Institute of Technology
 Tokyo Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CarnaBio USA, Inc.
CarnaBio USA, Inc. Medical DistributorsDistribution Services Wholesales kinases protein, substrates and biotinylates kinases products | Distribution Services |
ProbeX, Inc.
ProbeX, Inc. Medical/Nursing ServicesHealth Services Develops, manufactures, and distributes molecular imaging probe reagents | Health Services |
Kringle Pharma, Inc.
 Kringle Pharma, Inc. BiotechnologyHealth Technology Researches and develops treatments for regenerative medicine and cancer therapy | Health Technology |
